Check Out What Whales Are Doing With ELV
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bullish stance on Elevance Health (NYSE:ELV), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $420.0 to $465.0 for Elevance Health over the last 3 months. Cantor Fitzgerald downgraded its action to Overweight with a price target of $547. The price of ELV is currently $453.57, with next earnings expected in 6 days.
October 12, 2023 | 5:32 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Whale investor has taken a bullish stance on Elevance Health, with a targeted price range of $420-$465. Cantor Fitzgerald has downgraded its action to Overweight with a price target of $547. Current price is $453.57.
The bullish stance of the whale investor, along with the high price target set by Cantor Fitzgerald, indicates a positive short-term impact on Elevance Health's stock. However, the fact that 50% of investors have bearish expectations could introduce some volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100